Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease (Q35810844)

10 August 2017

1 reference

title

Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease (English)

1 reference

10 August 2017

Baaten BJ

1

1 reference

10 August 2017

Butter C

series ordinal

2

1 reference

10 August 2017

Davison TF

series ordinal

3

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Veterinary Immunology and Immunopathology

10 August 2017

published in

1 reference

10 August 2017

volume

100

1 reference

10 August 2017

issue

3-4

1 reference

10 August 2017

page(s)

165-177

1 reference

Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Vital involvement of a natural killer cell activation receptor in resistance to viral infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Development of cytoplasmic CD3+/T cell receptor-negative cells in the peripheral lymphoid tissues of chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Cytoplasmic CD3+ surface CD8+ lymphocytes develop as a thymus-independent lineage in chick-quail chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Effect of passively transfered immunoglobulins on Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Influence of Age at Exposure on the Pathogenesis of Marek's Disease 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Field Trials with a Bivalent Vaccine (HVT and SB-1) against Marek's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Further characterization of marek's disease virus-infected lymphocytes. II.In vitro infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Viral IL-6-induced cell proliferation and immune evasion of interferon activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Effect of maternal antibody on Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Agent of Marek's disease in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Anti-idiotype antibodies to Marek's disease-associated tumour surface antigen in protection against Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Genetic variation in susceptibility to Marek's disease in a commercial broiler population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

7 January 2021

Historical background

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Imperfect vaccines and the evolution of pathogen virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Characterization of avian natural killer cells and their intracellular CD3 protein complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

The role of the reticuloendothelial system in the immunopathology of Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

In Vitro Studies on the Role of the Macrophages of Resistant and Susceptible Chickens with Marek's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

The role of the macrophage in Marek's disease:In vitro andin vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Enhancement of natural killer cell activity by Marek's disease vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

v-src oncogene-specific carboxy-terminal peptide is immunoprotective against Rous sarcoma growth in chickens with MHC class I allele B-F12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Marek's disease virus down-regulates surface expression of MHC (B Complex) Class I (BF) glycoproteins during active but not latent infection of chicken cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Nitric oxide synthase activity and mRNA expression in chicken macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Marek's disease in broiler chickens: effect of route of infection and herpesvirus of turkey-vaccination status on detection of virus from blood or spleen by polymerase chain reaction, and on weights of birds, bursa and spleen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Presence and Survival of Marek's Disease Agent in Dust

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Marek's disease virus-induced antigens in relation to immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

A "minimal essential Mhc" and an "unrecognized Mhc": two extremes in selection for polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Transmission of classical Marek's disease by affected and carrier birds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Evidence for a genetic variation in the mitochondrial genome affecting traits in White Leghorn chickens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Mitochondrial PEPCK: a highly polymorphic gene with alleles co-selected with Marek's disease resistance in chickens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Nomenclature for chicken MHC (B) antigens defined by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Nitric oxide and macrophage function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Cytotoxic T lymphocyte responses to Marek's disease herpesvirus-encoded glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Lack of contact transmission of recombinant Marek's disease virus type 1 expressing the fusion protein of Newcastle disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Protection against Marek's Disease by Vaccination with a Herpesvirus of Turkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Effect of vaccination with herpesvirus of turkeys (HVT) on horizontal spread of Marek's disease herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Avian macrophage: effector functions in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Antiviral T cell-mediated immunity in Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Syngeneic and allogeneic cell-mediated cytotoxicity against marek's disease lymphoblastoid tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Specific and nonspecific immune responses to Marek's disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Studies on Acute Marek's Disease IV. Relative Susceptibility of Different Lines and Crosses of Chickens to GA Isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Avian Lymphomatosis. V. Air-Borne Transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Absence of age-resistance in neonatally thymectomised chickens as evidence for cell-mediated immune surveillance in Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Lack of a threshold of genetic resistance to Marek's disease and the incidence of humoral antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Natural Killer Cell Activity in Chickens Exposed to Marek's Disease Virus: Inhibition of Activity in Susceptible Chickens and Enhancement of Activity in Resistant and Vaccinated Chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Macrophage activation by T cells: cognate and non-cognate signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Cytotoxic activity of cells recovered from the respiratory tracts of chickens inoculated with infectious bronchitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Nonspecific cellular defense of the avian respiratory system: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

The genome of a very virulent Marek's disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Molecular-biological characterization of Marek's disease virus I. identification of virus-specific polypeptides in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Stages of Marek's disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Interferon modulation of Marek's disease virus genome expression in chicken cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Effects of avian viruses on cultured chicken bone-marrow-derived macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Growth inhibition of Marek's disease T-lymphoblastoid cell lines by chicken bone-marrow-derived macrophages activated in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Marek's disease research--history and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Influence of serotype and virus strain on synergism between Marek's disease vaccine viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Protective efficacy of Marek's disease vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Field Trials to Test the Efficacy of Polyvalent Marek's Disease Vaccines in Broilers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

Effects of Passive Antibody on Early Pathogenesis of Marek's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

7 January 2021

inferred from DOI database lookup

Pathogenesis of Marek's disease virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

7 January 2021

inferred from DOI database lookup

Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.04.009

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VETIMM.2004.04.009

1 reference

release_3kafvygxa5hstimmysiypyxffe

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3kafvygxa5hstimmysiypyxffe

24 November 2022

mapped directly with Wikidata item

1 reference